No, though this is one of the most resounding<\/em><\/strong> myths surrounding pharma compliance analytics. As we discovered to our own surprise, the formality and structure of Big Pharma can actually decelerate <\/em>the pace at which analytics programs are introduced or executed.<\/p>\n

The fact that Big Pharma often has the financial muscle to develop in-house compliance\/analytics programs can mean that such programs lack the cross-pollinating insights of plug-and-play solutions developed by specialized SaaS vendors.<\/p>\n

<\/span>Question #4: True or False? \u201cLots of data means a robust analytics program.\u201d<\/span><\/h2>\n

False. Especially if you\u2019re just starting out with your compliance program.<\/p>\n

\u201cDon\u2019t bite off more than you can chew\u201d is sound advice, coming from no less than Ishita Arora, Manager Compliance at Horizon Pharma and our webinar host earlier this month.<\/p>\n

As you probably realize, a prevailing trait of compliance\/transparency professionals is that they like to get things right the first <\/em>time. With small datasets, you\u2019re:<\/p>\n

\n
• Less likely to make mistakes<\/li>\n
• Identify outliers and irregularities<\/li>\n
• Implement corrective action<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"

  Still unsure about introducing a compliance analytics program into your company? You\u2019re not alone. Of the 9272* medical drug and device companies in the USA, only 1,481 submitted their CMS report in 2016, down from 1,579 in 2015. While for some, macro issues like M&A and CIAs may explain the lack of a report, other […]<\/p>\n","protected":false},"author":118,"featured_media":22213,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[199,201],"tags":[],"class_list":["post-14553","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aggregate-spend-reporting","category-compliance-data-analytics"],"acf":[],"_links":{"self":[{"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/posts\/14553","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/users\/118"}],"replies":[{"embeddable":true,"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/comments?post=14553"}],"version-history":[{"count":4,"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/posts\/14553\/revisions"}],"predecessor-version":[{"id":19887,"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/posts\/14553\/revisions\/19887"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/media\/22213"}],"wp:attachment":[{"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/media?parent=14553"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/categories?post=14553"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/tags?post=14553"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}